HARRY JR PENNER

CIK 1131148 · last filed 2025-06-09

HARRY JR PENNER is a corporate insider who has filed 26 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for CLDX, was dated Jun 9, 2025.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

26

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CLDX Director $31.27 $0 7 2025-06-09
Altus Pharmaceuticals Inc. (ALTU) Delisted Director $10.12 $0 4 2009-07-02
Celldex Therapeutics, Inc. (AVAN) Delisted Director $10.04 $0 1 2008-09-29
Celldex Therapeutics, Inc. (AVAND) Delisted Director $0 1 2008-03-11

Recent Filings

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-06-09 CLDX Grant (A) $0 EDGAR
2024-06-17 CLDX Grant (A) $0 EDGAR
2023-06-20 CLDX Grant (A) $0 EDGAR
2022-06-17 CLDX Grant (A) $0 EDGAR
2021-06-21 CLDX Grant (A) $0 EDGAR
2020-06-19 CLDX Grant (A) $0 EDGAR
2019-06-20 CLDX Grant (A) $0 EDGAR
2018-06-15 Grant (A) $0
2017-06-16 Grant (A) +10,000 $0
2016-06-09 Grant (A) +10,000 $0
Showing 110 of 26
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.